Cargando…

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line

The present study aimed to engineer a nanoscale lipid-based lymphatic drug delivery system with D-α-Tocopherol polyethylene glycol 1000 succinate to combat the lymphatic metastasis of lung cancer. The nanoscale lipid-based systems including GEF-SLN, GEF-NLC, and GEF-LE were prepared and pharmaceutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherif, Abdelrahman Y., Harisa, Gamaleldin I., Alanazi, Fars K., Nasr, Fahd A., Alqahtani, Ali S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247939/ https://www.ncbi.nlm.nih.gov/pubmed/35773422 http://dx.doi.org/10.1208/s12249-022-02332-7

Ejemplares similares

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons
por: Harisa, Gamaleldin I., et al.
Publicado: (2023)

Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer
por: Sherif, Abdelrahman Y., et al.
Publicado: (2023)

Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability
por: Faris, Tarek M., et al.
Publicado: (2020)

The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study
por: Harisa, Gamaleldin I., et al.
Publicado: (2015)

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
por: Harisa, Gamaleldin I., et al.
Publicado: (2013)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells
por: Alhadad, Laila J., et al.
Publicado: (2020)

Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles
por: Elzayat, Ehab M., et al.
Publicado: (2023)

Pravastatin chitosan nanogels-loaded erythrocytes as a new delivery strategy for targeting liver cancer
por: Harisa, Gamaleldin I., et al.
Publicado: (2016)

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition
por: Alanazi, Saleh A., et al.
Publicado: (2021)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

Development, Characterization Optimization, and Assessment of Curcumin-Loaded Bioactive Self-Nanoemulsifying Formulations and Their Inhibitory Effects on Human Breast Cancer MCF-7 Cells
por: Kazi, Mohsin, et al.
Publicado: (2020)

Characterization of Human Erythrocytes as Potential Carrier for Pravastatin: An In Vitro Study
por: Harisa, Gamal El-din I., et al.
Publicado: (2011)

Novel in-situ gel for intravesical administration of ketorolac
por: Sherif, Abdelrahman Y., et al.
Publicado: (2018)

Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus
por: Kazi, Mohsin, et al.
Publicado: (2020)

Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines
por: Alshetaili, Abdullah S.
Publicado: (2021)

Role of Alternative Lipid Excipients in the Design of Self-Nanoemulsifying Formulations for Fenofibrate: Characterization, in vitro Dispersion, Digestion and ex vivo Gut Permeation Studies
por: Alshamsan, Aws, et al.
Publicado: (2018)

Cytotoxic and apoptotic effects of Ebenus boissieri Barbey on human lung cancer cell line A549
por: Aydemir, Esra Arslan, et al.
Publicado: (2015)

Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells
por: Noman, Omar, et al.
Publicado: (2023)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
por: Kwon, Taeho, et al.
Publicado: (2015)

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign
por: Alshora, Doaa H., et al.
Publicado: (2018)

Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS) for Combined Oral Delivery of Curcumin and Piperine
por: Kazi, Mohsin, et al.
Publicado: (2020)

Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells
por: Md, Shadab, et al.
Publicado: (2020)

The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting
por: Fujisaka, Yasuhito, et al.
Publicado: (2023)

The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study
por: Alqahtani, Ali S., et al.
Publicado: (2022)

Valsartan prevents gefitinib-induced lung inflammation, oxidative stress, and alteration of plasma metabolites in rats
por: Alanazi, Wael A., et al.
Publicado: (2023)

Apoptotic Induction and Anti-Migratory Effects of Rhazya Stricta Fruit Extracts on a Human Breast Cancer Cell Line
por: Al-Zharani, Mohammed, et al.
Publicado: (2019)

Pravastatin Provides Antioxidant Activity and Protection Of Erythrocytes Loaded Primaquine
por: Alanazi, Fars
Publicado: (2010)

Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity
por: Ibrahim, Mohamed A., et al.
Publicado: (2019)

Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases
por: Kjellman, Pontus, et al.
Publicado: (2015)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
por: Alyami, Hamad S, et al.
Publicado: (2021)

Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation
por: Bahadori, Fatemeh, et al.
Publicado: (2017)

Effect of A549 neuroendocrine differentiation on cytotoxic immune response
por: Mendieta, Irasema, et al.
Publicado: (2018)

Cytotoxic Evaluation and Anti-Angiogenic Effects of Two Furano-Sesquiterpenoids from Commiphora myrrh Resin
por: S. Alqahtani, Ali, et al.
Publicado: (2020)

Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
por: Bachawal, Sunitha V, et al.
Publicado: (2010)

Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells
por: Koyama, Satoshi, et al.
Publicado: (2015)

Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells
por: Hu, Chun-Sheng, et al.
Publicado: (2021)

Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac
por: Elzayat, Ehab Mostafa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fc9k3ud2ldq2pd4jrpokid8cnu